8-K//Current report
Revance Therapeutics, Inc. 8-K
Accession 0001193125-25-021403
CIK 0001479290operating
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 8:59 AM ET
Size
345.7 KB
Accession
0001193125-25-021403
Documents
- 8-Kd914912d8k.htmPrimary
8-K
- EX-3.1d914912dex31.htm
EX-3.1
- EX-3.2d914912dex32.htm
EX-3.2
- EX-4.1d914912dex41.htm
EX-4.1
- EX-99.1d914912dex991.htm
EX-99.1
- EX-101.SCHrvnc-20250206.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABrvnc-20250206_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PRErvnc-20250206_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICg914912g0206105038584.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-021403-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd914912d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001479290
Filing Metadata
- Form type
- 8-K
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 8:59 AM ET
- Size
- 345.7 KB